Brief: ADC Therapeutics Announces Pricing Of Underwritten Offering
02/02/2023 13:23
Feb 2 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN
OFFERING BY A
SELLING SHAREHOLDER
* ADC THERAPEUTICS - PRICING OF UNDERWRITTEN OFFERING OF 12
MILLION COMMON SHARES OF CO CURRENTLY OWNED BY SELLING
SHAREHOLDER AT A PRICE OF $5.00 PER SHARE
Source text for Eikon: ID:nBw3kxTTda
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview